Hepatic IFIT3 Predicts Interferon-Α Therapeutic Response in Patients of Hepatocellular Carcinoma

Hepatology - United States
doi 10.1002/hep.29156
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Level of Α-Fetoprotein Predicts Mortality Among Patients With Hepatitis C–Related Hepatocellular Carcinoma

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2011English

Lipiodol Retention Pattern Predicts Transarterial Chemoembolization Therapeutic Effect in Hepatocellular Carcinoma

Universa Medicina
2016English

Shear Wave Elastography Predicts Hepatocellular Carcinoma Risk in Hepatitis C Patients After Sustained Virological Response

PLoS ONE
Multidisciplinary
2018English

Early Α-Fetoprotein Response Predicts Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib

Journal of Hepatocellular Carcinoma
2015English

PDCD5 Expression Predicts a Favorable Outcome in Patients With Hepatocellular Carcinoma

International Journal of Oncology
Cancer ResearchOncology
2013English

Radiographic Response to Locoregional Therapy in Hepatocellular Carcinoma Predicts Patient Survival Times

2011English

Transcatheter Arterial Embolization of Hepatic Arteriovenous Shunts in Patients With Hepatocellular Carcinoma

Seminars in Interventional Radiology
Nuclear MedicineRadiologyCardiovascular MedicineImagingCardiology
2012English

Increased Programmed Death Ligand-1 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma Patients

OncoTargets and Therapy
OncologyPharmacology
2016English

Recurrent Hepatocellular Carcinoma After Hepatic Resection

The journal of the Japanese Practical Surgeon Society
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy